AxoGen Inc (AXGN)

11.50
0.05 0.44
NASDAQ : Health Care
Prev Close 11.45
Open 11.55
Day Low/High 11.40 / 11.60
52 Wk Low/High 3.26 / 7.97
Volume 201.97K
Avg Volume 144.40K
Exchange NASDAQ
Shares Outstanding 33.06M
Market Cap 386.85M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Exelon, Valley National Bancorp, Skyworks Solutions: 'Mad Money' Lightning Round

Exelon, Valley National Bancorp, Skyworks Solutions: 'Mad Money' Lightning Round

Jim Cramer is bullish on Exelon and Valley National Bancorp, but he's bearish on AxoGen and SeaDrill Limited.

The Real Trump Trade May Be Gold: Cramer's 'Mad Money' Recap (Tuesday 4/11/17)

The Real Trump Trade May Be Gold: Cramer's 'Mad Money' Recap (Tuesday 4/11/17)

Political negatives keep popping up, forcing us to rethink the Trump trade, says Jim Cramer.

AxoGen Reaches Analyst Target Price

AxoGen Reaches Analyst Target Price

In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $10.31, changing hands for $10.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AxoGen Appoints Ivica Ducic Medical Director

AxoGen Appoints Ivica Ducic Medical Director

Peripheral Nerve Surgery Expert Brings More Than 15 Years of Clinical Experience to AxoGen

AxoGen To Participate At AAHS ASPN ASRM Joint 2017 Annual Meeting

AxoGen To Participate At AAHS ASPN ASRM Joint 2017 Annual Meeting

AxoGen to host expert panel discussion and interactive session on new nerve repair technologies

AxoGen Reaches Analyst Target Price

AxoGen Reaches Analyst Target Price

In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.92, changing hands for $8.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AxoGen, Inc. Announces Commercial Release And First Clinical Implant Of Avive™ Soft Tissue Membrane

AxoGen, Inc. Announces Commercial Release And First Clinical Implant Of Avive™ Soft Tissue Membrane

Expanded Nerve Product Portfolio and Other Business Updates to be Discussed Today at AxoGen's Analyst & Investor Event

AXGN Crosses Above Average Analyst Target

AXGN Crosses Above Average Analyst Target

In recent trading, shares of AxoGen Inc have crossed above the average analyst 12-month target price of $8.25, changing hands for $8.55/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

AxoGen, Inc. Reports Financial Results For Third Quarter 2016

AxoGen, Inc. Reports Financial Results For Third Quarter 2016

Record revenues of $11.2 million, continued growth in accounts, and increased presence of nerve repair at key medical meetings    

AxoGen, Inc. Announces The Refinancing Of Its Debt Facility

AxoGen, Inc. Announces The Refinancing Of Its Debt Facility

New Agreement Will Replace Existing $25 million Term Loan and Revenue Interest Royalty Agreement, and Reduce Annual Interest Costs by at Least $1.5 Million

Commit To Purchase AxoGen At $7.50, Earn 17.1% Annualized Using Options

Commit To Purchase AxoGen At $7.50, Earn 17.1% Annualized Using Options

Investors considering a purchase of AxoGen Inc stock, but cautious about paying the going market price of $8.77/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2017 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.

AxoGen, Inc. Appoints Amy Wendell To Board Of Directors  

AxoGen, Inc. Appoints Amy Wendell To Board Of Directors  

Former Covidien Senior Executive Brings More Than 30 Years of Experience to AxoGen Board

AxoGen To Participate At 71st Annual American Society For Surgery Of The Hand Meeting

AxoGen To Participate At 71st Annual American Society For Surgery Of The Hand Meeting

Expanded Role of Nerve Awareness and Repair in 30 Separate Conference Sessions and Presentations

AxoGen, Inc. To Participate At The American Association Of Oral And Maxillofacial Surgeons 98th Annual Meeting

AxoGen, Inc. To Participate At The American Association Of Oral And Maxillofacial Surgeons 98th Annual Meeting

Increasing Awareness of Nerve Injury and Repair in Multiple Conference Presentations